Skip to main content
Clinical Trials/CTRI/2020/06/026074
CTRI/2020/06/026074
Not yet recruiting
未知

Prevalence of Diabetic Peripheral Neuropathy among Type 2 Diabetes Mellitus patients and impact of high dose of Methylcobalamine in patients with Diabetic Peripheral Neuropathy in Urban Etawah: An interventional Study

self sponsored intramural0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: E114- Type 2 diabetes mellitus with neurological complicationsHealth Condition 2: E114- Type 2 diabetes mellitus with neurological complications
Sponsor
self sponsored intramural
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
self sponsored intramural

Eligibility Criteria

Inclusion Criteria

  • All known diabetics more than or equal to five years

Exclusion Criteria

  • 1\.Patients already on methyl\-cobalamine treatment
  • 2\.Patients who were severely ill, mentally challenged or unable to communicate
  • 3\.Patients with chronic lower back pain, neurological history and clinical examination suggestive of myelopathies
  • 4\.Pregnant women and patients taking medication known to impair nerve function.
  • 5\.Patients not willing to participate in study

Outcomes

Primary Outcomes

Not specified

Similar Trials